ZyVersa Therapeutics Engages CRO, George Clinical, for Phase 2a Clinical Trial for Cholesterol Efflux Mediator VAR 200
14 déc. 2023 07h01 HE
|
ZyVersa Therapeutics
ZyVersa engages CRO, George Clinical, to manage its P2a clinical trial with VAR 200 in Diabetic Kidney Disease expected to begin Q1-2024.
George Clinical to Accelerate International Growth Through Acquisition by Hillhouse
09 déc. 2022 03h00 HE
|
George Clinical
SYDNEY, Dec. 09, 2022 (GLOBE NEWSWIRE) -- George Clinical announces that it has entered into a sale agreement with Hillhouse, a global investment firm with deep experience in partnering with and...
George Clinical Recruits More than 5,000 Patients in the Global Kidney Patient Trials Network
25 oct. 2022 10h00 HE
|
George Clinical
OVERLAND PARK, Ks., Oct. 25, 2022 (GLOBE NEWSWIRE) -- George Clinical, in close collaboration with The George Institute for Global Health, has recently announced the recruitment of more than 5,000...
George Clinical Expands China Team with New Project Director and Cell Gene Therapy Head Helen Xu
08 sept. 2022 13h00 HE
|
George Clinical
BEIJING, Sept. 08, 2022 (GLOBE NEWSWIRE) -- George Clinical, a global clinical research organization with an extensive presence throughout the Asia-Pacific region, continues to expand the...
George Clinical Grows Scientific Leadership to Include Latin America with the Addition of Renal Expert Hernán Trimarchi
01 mars 2022 13h00 HE
|
George Clinical
OVERLAND PARK, KS., March 01, 2022 (GLOBE NEWSWIRE) -- George Clinical announces the expansion of its renal scientific leadership into Latin America with the addition of subject matter expert Hernán...
George Clinical Accredited for Gene Technology Clinical Research
03 févr. 2022 10h40 HE
|
George Clinical
SYDNEY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a...
Noteworthy Renal Research Progress Highlighted by George Clinical Scientific Leaders During ASN Kidney Week
12 nov. 2021 10h00 HE
|
George Clinical
OVERLAND PARK, KS., Nov. 12, 2021 (GLOBE NEWSWIRE) -- New kidney and metabolic research involving George Clinical teams and scientific leaders has received global attention during the 2021 American...
Neuropharmacologist and CRO Veteran Graham Birrell Joins George Clinical to Lead APAC Operations
18 oct. 2021 10h00 HE
|
George Clinical
SYDNEY, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Graham Birrell, PhD, MBA, a researcher and neuropharmacologist with significant clinical research experience in the EU and Asia-Pacific region has joined...